OpenAI announced that an internal AI system deployed a swarm of roughly 10,000 concurrent agents over 88 hours to produce a formal Lean-verified proof addressing the Navier–Stokes Millennium Prize Problem. Meanwhile, a study published in Nature Biotechnology revealed that Insilico Medicine's AI-designed drug rentosertib significantly reduced biological age markers across six independent proteomic clocks in a Phase 2a trial.

We’ll talk about:

A 10,000-agent AI swarm utilizing 130B output tokens to generate a 165-page proof and Lean formalization of finite-time blowup in fluid dynamics.
Phase 2a trial data showing an AI-designed idiopathic pulmonary fibrosis drug reduced biological age markers by up to 3–4 years across six proteomic aging clocks.
OpenAI deploying its upgraded image generation model featuring faster generation speeds, improved subject consistency, and higher visual fidelity.
Applied AI startup Cognition securing $2 billion in new capital at a $52B valuation as its annualized revenue run rate reaches $900 million.

Keywords: OpenAI Navier Stokes, ChatGPT Images 2.5, Cognition, Meta Muse.

Links:

Newsletter: Sign up for our FREE daily newsletter.
Our Community: Get 3-level AI tutorials across industries.
Join AI Fire Academy: 700+ advanced AI workflows ($14,500+ Value)

Our Socials:

Facebook Group: Join 298K+ AI builders
X (Twitter): Follow us for daily AI drops
YouTube: Watch AI walkthroughs & tutorials

🎙️ EP 351: OpenAI to Navier–Stokes Problem & Insilico AI Drug Shows Anti-Aging Signal

AI Fire Daily

🎙️ EP 351: OpenAI to Navier–Stokes Problem & Insilico AI Drug Shows Anti-Aging Signal